Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Tarsus Pharmaceuticals, Inc. TARS

Set alert

Price alert · TARS

All alert types
75.03 USD +1.71 +2.33%

As of Nov 3, 11:13 AM ET

Bid
74.91 × 2
Ask
75.07 × 1
74.10 Day range 75.20
53.89 52-week range 91.53
YTD
-8.37%
1 year
+7.50%
Open
74.30
Prev close
73.32
Mkt cap
3.51B
Vol
87.89K
Avg vol
828.48K
EPS
-1.08
P/E
0.00
Div yield
0.00%
More statistics
Low
74.10
High
75.20
Forward P/E
-146.64
Beta
0.33
Short ratio
6.62
Inst. own
99.26%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
75.16
200-d avg
67.78
1y target
98.89

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for TARS has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

8.30 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -51.5×
FY 2018: -66.4×FY 2019: -85.8×FY 2020: -31.3×FY 2021: -33.6×FY 2022: -5.8×FY 2023: -4.4×FY 2024: -18.0×FY 2025: -51.5×
FY 2018 5y median -18.0× FY 2025
P/S 7.6×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 8.1×FY 2022: 14.0×FY 2023: 34.1×FY 2024: 11.4×FY 2025: 7.6×
FY 2018 5y median 11.4× FY 2025
P/B 10.0×
FY 2018: -65.1×FY 2019: -66.9×FY 2020: 5.1×FY 2021: 2.8×FY 2022: 1.9×FY 2023: 3.0×FY 2024: 9.3×FY 2025: 10.0×
FY 2018 5y median 3.0× FY 2025
P/FCF -153×
FY 2018: -74.1×FY 2019: -104×FY 2020: -38.9×FY 2021: 146×FY 2022: -7.3×FY 2023: -4.8×FY 2024: -24.6×FY 2025: -153×
FY 2018 5y median -7.3× FY 2025
EV/EBITDA -62.1×
FY 2018: -65.2×FY 2019: -75.5×FY 2020: -25.2×FY 2021: -21.8×FY 2022: -5.2×FY 2023: -3.0×FY 2024: -19.3×FY 2025: -62.1×
FY 2018 5y median -19.3× FY 2025
EV/Sales 7.4×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 5.1×FY 2022: 12.0×FY 2023: 22.9×FY 2024: 11.3×FY 2025: 7.4×
FY 2018 5y median 11.3× FY 2025
FCF Yield -0.7%
FY 2018: -1.3%FY 2019: -1.0%FY 2020: -2.6%FY 2021: 0.7%FY 2022: -13.7%FY 2023: -20.7%FY 2024: -4.1%FY 2025: -0.7%
FY 2018 5y median -4.1% FY 2025

Profitability

Gross Margin 93.2%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 96.4%FY 2022: 96.3%FY 2023: 90.9%FY 2024: 93.0%FY 2025: 93.2%
FY 2018 5y median 93.2% FY 2025
Operating Margin -15.7%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -21.3%FY 2022: -242.9%FY 2023: -820.5%FY 2024: -65.9%FY 2025: -15.7%
FY 2018 5y median -65.9% FY 2025
Net Margin -14.7%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -24.2%FY 2022: -240.5%FY 2023: -778.9%FY 2024: -63.2%FY 2025: -14.7%
FY 2018 5y median -63.2% FY 2025
ROE -19.3%
FY 2018: 97.4%FY 2019: 77.8%FY 2020: -16.2%FY 2021: -8.3%FY 2022: -32.2%FY 2023: -69.0%FY 2024: -51.5%FY 2025: -19.3%
FY 2018 5y median -32.2% FY 2025
ROIC -16.6%
FY 2018: -61.1%FY 2019: -7.5%FY 2020: -16.2%FY 2021: -7.2%FY 2022: -29.4%FY 2023: -62.5%FY 2024: -40.6%FY 2025: -16.6%
FY 2018 5y median -29.4% FY 2025
ROA -11.8%
FY 2018: -55.2%FY 2019: -8.0%FY 2020: -15.6%FY 2021: -7.7%FY 2022: -27.2%FY 2023: -51.2%FY 2024: -30.7%FY 2025: -11.8%
FY 2018 5y median -27.2% FY 2025

Growth (YoY)

Revenue 146.7%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -54.7%FY 2023: -32.4%FY 2024: 948.6%FY 2025: 146.7%
FY 2018 FY 2025
Operating Income 41.1%
FY 2018: 0.0%FY 2019: -218.4%FY 2020: -527.8%FY 2021: 54.9%FY 2022: -415.9%FY 2023: -128.3%FY 2024: 15.8%FY 2025: 41.1%
FY 2018 FY 2025
EPS (diluted) 48.2%
FY 2018: 0.0%FY 2019: 22.6%FY 2020: -450.0%FY 2021: 49.2%FY 2022: -276.1%FY 2023: -83.3%FY 2024: 33.5%FY 2025: 48.2%
FY 2018 FY 2025
Free Cash Flow 73.6%
FY 2018: 0.0%FY 2019: -223.4%FY 2020: -461.2%FY 2021: 114.6%FY 2022: -1666.6%FY 2023: -148.3%FY 2024: 31.2%FY 2025: 73.6%
FY 2018 FY 2025

Financial Health

Current Ratio 3.9×
FY 2018: 13.3×FY 2019: 70.9×FY 2020: 31.7×FY 2021: 15.3×FY 2022: 14.6×FY 2023: 6.9×FY 2024: 4.4×FY 2025: 3.9×
FY 2018 5y median 6.9× FY 2025
Quick Ratio 3.8×
FY 2018: 13.3×FY 2019: 70.9×FY 2020: 31.7×FY 2021: 15.3×FY 2022: 14.6×FY 2023: 6.9×FY 2024: 4.4×FY 2025: 3.8×
FY 2018 5y median 6.9× FY 2025
Debt / Equity 0.3×
FY 2018: 0.0×FY 2019: -0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.3×FY 2025: 0.3×
FY 2018 5y median 0.2× FY 2025
Net Debt / EBITDA 1.7×
FY 2018: 1.8×FY 2019: 12.7×FY 2020: 6.3×FY 2021: 12.6×FY 2022: 0.9×FY 2023: 1.5×FY 2024: 0.2×FY 2025: 1.7×
FY 2018 5y median 1.5× FY 2025
Interest Coverage -7.9×
FY 2018: 0.0×FY 2019: -107×FY 2020: -144×FY 2021: 0.0×FY 2022: -30.4×FY 2023: -44.4×FY 2024: -16.2×FY 2025: -7.9×
FY 2018 5y median -16.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31